141946-05-6 Usage
Molecular Structure
1-Thien-2-yl-1,4-dihydro-5H-tetrazole-5-one is a heterocyclic compound with a five-membered ring containing four carbon atoms and one sulfur atom, along with two nitrogen atoms.
Usage
Thienotetrazole is commonly used in the pharmaceutical industry as a building block for the synthesis of various biologically active compounds, particularly drugs with cardiovascular and central nervous system effects.
Acidic and Basic Properties
Thienotetrazole exhibits both acidic and basic properties, making it useful in the synthesis of a wide range of pharmaceuticals.
Metal Ion Complexation
Thienotetrazole is known for its ability to form complexes with various metal ions, which has potential applications in catalysis and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 141946-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,9,4 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 141946-05:
(8*1)+(7*4)+(6*1)+(5*9)+(4*4)+(3*6)+(2*0)+(1*5)=126
126 % 10 = 6
So 141946-05-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H4N4OS/c10-5-6-7-8-9(5)4-2-1-3-11-4/h1-3H,(H,6,8,10)
141946-05-6Relevant articles and documents
Tetrazolinone derivatives
-
, (2008/06/13)
Herbicidal novel tetrazolinone derivatives of the formula: STR1 wherein R1 is alkyl, haloalkyl, cycloalkyl, alkenyl, haloalkenyl, alkynyl, alkoxy or phenyl which is optionally substituted, and R2 is alkyl, haloalkyl, cycloalkyl, alkenyl, haloalkenyl, alkynyl, alkoxy or phenyl which is optionally substituted, or R1 and R2 form, together with the nitrogen atom to which R1 and R2 are bonded, a 5- or 6-membered heterocyclic ring, optionally fused to a carbocyclic ring optionally and independently substituted by C1-4 alkyl, and R3 is a 5-membered heterocyclic radical containing at least one hereto atom selected from the group consisting of nitrogen, oxygen, and sulfur, optionally substituted by at least one substitutent selected from the group consisting of halogen, benzyl, phenyl, halogen-substituted phenyl, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, C1-4 alkylthio, C1-4 alkyl-sulfonyl and C3-8 cycloalkyl, processes for their preparation and novel intermediates therefor.
